Revolution Medicines
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -4,535 | -4,702 | ||
EBITDA | -620,590 | -437,084 | -348,254 | -289,440 |
EBIT | -441,619 | -352,956 | -293,778 | |
Net Income | -644,371 | -453,816 | -364,892 | -305,206 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -745,308 | -355,703 | -276,163 | -210,660 |
Cash | 815,435 | 440,939 | 383,745 | 217,442 |
Basic Shares | 210,893 | 198,098 | 190,129 | 189,231 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $11,580 | $35,380 |
Gross Profit | -16,558 | -592,225 | 11,580 | 35,380 |
EBITDA | -1,090,512 | -589,022 | -430,279 | -239,469 |
EBIT | -1,107,070 | -600,846 | -439,588 | -249,125 |
Net Income | -1,131,301 | -600,093 | -436,367 | -248,705 |
Net Change In Cash | 0 | 0 | 11,580 | 35,380 |
Free Cash Flow | -913,731 | -567,744 | -358,301 | -235,217 |
Cash | 383,745 | 543,064 | 696,148 | 161,412 |
Basic Shares | 190,129 | 167,737 | 113,149 | 80,626 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$2.34 |
2026-03-31 | -$2.29 |
2025-12-31 | -$1.86 |
2025-09-30 | -$1.61 |